Gene Mutation Found to Reduce Dalbavancin Sensitivity
Researchers linked StpA gene mutations in Enterococcus faecium to diminished susceptibility to the antibiotic dalbavancin.
Updated on Oct. 21, 2026 in Life Sciences
Scientists discovered that missense mutations in the StpA gene allow Enterococcus faecium to resist dalbavancin, a powerful antibiotic. These mutations trigger widespread changes in cell wall structure and division regulation, rendering the drug significantly less effective.
Why it matters
Understanding this resistance mechanism provides critical insight into how bacteria evolve to survive antibiotic treatment. This discovery highlights the role of StpA-dependent envelope remodeling in clinical antibiotic evasion.
Researchers observed that mutants possessed thicker cell walls characterized by 3-3 cross-links and global hyperphosphorylation of cell-division regulators. These alterations resulted in a concentration-dependent reduction of dalbavancin binding.
The details
The study utilized spontaneous mutants selected in vitro from vancomycin-susceptible bacterial backgrounds to observe how StpA impacts antibiotic efficacy. Complementation with wild-type alleles restored drug susceptibility, confirming the gene's role in the observed resistance.
Timeline
The findings were formally published in a research article on October 21, 2026.
The Big Picture
This discovery fundamentally shifts the understanding of antibiotic resistance within the ongoing research into antibiotic resistance mechanisms in Enterococcus faecium. It bridges a gap by explaining how phosphatase-driven envelope changes act as a defensive barrier against glycopeptide antibiotics.
This research provides a template for future drug development strategies aimed at targeting specific bacterial proteins to prevent antibiotic resistance. By identifying the StpA pathway, scientists can now focus on creating inhibitors that restore the efficacy of current antibiotics like dalbavancin.
The takeaway
Bacteria can develop resistance through complex internal structural changes rather than just simple drug avoidance. Researchers suggest that targeting cell wall biosynthesis proteins like MurA may prove essential in maintaining the efficacy of clinical antibiotics.
Further reading
Learn more about advancements in Life Sciences regarding bacterial genetics.
More information
Review the full peer-reviewed research article for further technical data.
Source note: This article includes information reported by Nature.
